Lifestyle

SoundHound AI specializes in advanced voice-enabled technology, offering more intuitive user experiences by processing conversational nuances. The company is becoming a leader in integrating voice technology across various industries, including automotive and home automation. Partnerships with major corporations are driving SoundHound’s stock

Eli Lilly integrates AI to personalise diabetes care, enhancing treatment effectiveness and patient outcomes. Stock growth reflects investor confidence in the company’s AI-driven innovations and strategic partnerships. Lilly’s innovative pricing strategies aim to improve global healthcare accessibility and trust, boosting their market

Eli Lilly is set to announce its Q4 2024 earnings, generating strong market interest. The company is expected to report £13.5 billion in revenue, a 45% year-over-year increase. Investors are hopeful due to rising demand for weight-loss drugs like Mounjaro and Zepbound.